Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
British Journal of Haematology|April 25, 2018
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomasAdam J Olszewski, Thomas Ollila, John L ReaganThe Annals of Thoracic Surgery|November 17, 2016
Embolization of Inferior Vena Cava Filter Tyne and Right Ventricular Perforation: A Cardiac MissileThomas Ollila, Syed Naeem, Athena Poppas, et al.JCO Oncology Practice|February 3, 2022
Analysis of Hematology and Oncology Fellowship Website Content and Diversity RepresentationArun Muthiah, Vanya Aggarwal, Chandrasekar Muthiah, et al.The Oncologist|May 31, 2022
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I StudyThomas Ollila, James Butera, Pamela Egan, et al.Blood Cancer Journal|March 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapyReem Karmali, Geoffrey Shouse, Pallawi Torka, et al.Cancers|July 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CARTNicole J Altomare, Megan M Herr, Nisha M Nair, et al.Journal of Hematology & Oncology|November 10, 2023
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyNarendranath Epperla, Lei Feng, Nirav N Shah, et al.Blood Advances|September 12, 2022
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHLJoanna Zurko, Imran Nizamuddin, Narendranath Epperla, et al.Pageof 1